Focuses on the clinical efficacy and safety of isosorbide mononitrate immediate-release sustained-release (IR-SR) formulation to see whether theoretical advantages translate into better clinical effectiveness. Formulations advantage over conventional isosorbide mononitrate or dinitrate; Rapid onset action of IR-SR; Antianginal effects.